James Hippel, Chief Financial Officer at BIO-TECHNE Corp (TECH), sold 18,500 shares at $331.61 ($6.2M) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Open-market sale of $6.2M TECH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $328.68 | 400 | $131K | 2.1% |
| 2 | $330.27 | 400 | $132K | 2.1% |
| 3 | $331.61 | 700 | $232K | 3.8% |
| 4 | $333.23 | 2,501 | $833K | 13.5% |
| 5 | $333.23 | 2,501 | $833K | 13.5% |
| 6 | $334.39 | 3,990 |
| $1.3M |
| 21.6% |
| 7 | $334.39 | 3,990 | $1.3M | 21.6% |
| 8 | $334.98 | 2,009 | $673K | 10.9% |
| 9 | $334.98 | 2,009 | $673K | 10.9% |
| Total | $333.89 avg | 18,500 | $6.2M | 100% |
| Filing → |
| TECH | SELL | 2021-09-07 | $10.1M | — | Filing → |
| TECH | SELL | 2021-08-10 | $4.8M | — | Filing → |
| TECH | SELL | 2021-07-14 | $8.0M | — | Filing → |